Clinical Characteristics and Therapeutic Management of Atopic Dermatitis in Elderly Patients Compared with Young Adult Patients: A Prospective Multicentre Study
DOI:
https://doi.org/10.2340/actadv.v104.40420Keywords:
Prevalence, Registries, Aged, Atopic Dermatitis, Observational StudyAbstract
Atopic dermatitis (AD) is the most common chronic inflammatory dermatitis in developed countries, and has a major impact on those affected. Little is known about AD in elderly patients. This prospective multicentre observational study described the clinical characteristics and burden of AD in elderly subjects ≥ 65 years, as well as the therapeutic options chosen for this population in routine care, and compared findings with those in young adults with AD < 30 years. Cohort data from adult patients with moderate-to-severe AD enrolled in a French national prospective registry (December 2020 to May 2023) were analysed. Patients ≥ 65 years made up 12.5% of the total adult cohort and presented less head-and-neck and extremity involvement, and were less affected by generalized forms than young adult patients. Elderly patients predominantly had late-onset AD and had similar disease severity to younger adults. Although the overall impact of AD appeared to be lower in elderly patients and treatment was initially less used in this age group, the substantial impact on sleep and psychiatric comorbidities was similar in older and younger adult patients. Better understanding of AD in elderly patients and the establishment of age-specific treatment guidelines may help dermatologists manage the disease in older people.
Downloads
References
Bylund S, Von Kobyletzki LB, Svalstedt M, Svensson A. Prevalence and incidence of atopic dermatitis: a systematic review. Acta Derm Venereol 2020; 100: 320-329.
https://doi.org/10.2340/00015555-3510
de Bruin-Weller M, Gadkari A, Auziere S, Simpson EL, Puig L, Barbarot S, et al. The patient-reported disease burden in adults with atopic dermatitis: a cross-sectional study in Europe and Canada. J Eur Acad Dermatol Venereol 2020; 34: 1026-1036.
https://doi.org/10.1111/jdv.16003
Drucker AM, Wang AR, Li WQ, Sevetson E, Block JK, Qureshi AA. The burden of atopic dermatitis: summary of a report for the National Eczema Association. J Invest Dermatol 2017; 137: 26-30.
https://doi.org/10.1016/j.jid.2016.07.012
Laughter MR, Maymone MBC, Mashayekhi S, Arents BWM, Karimkhani C, Langan SM, et al. The global burden of atopic dermatitis: lessons from the Global Burden of Disease Study 1990-2017. Br J Dermatol 2021; 184: 304-309.
https://doi.org/10.1111/bjd.19580
Bieber T. Atopic dermatitis. N Engl J Med 2008; 358: 1483-1494.
https://doi.org/10.1056/NEJMra074081
Bieber T, D'Erme AM, Akdis CA, Traidl-Hoffmann C, Lauener R, Schäppi G, et al. Clinical phenotypes and endophenotypes of atopic dermatitis: where are we, and where should we go? J Allergy Clin Immunol 2017; 139: S58-64.
https://doi.org/10.1016/j.jaci.2017.01.008
Salava A, Rieppo R, Lauerma A, Salo V. Age-dependent distribution of atopic dermatitis in primary care: a nationwide population-based study from Finland. Acta Derm Venereol 2022; 102: adv00738.
https://doi.org/10.2340/actadv.v102.2287
Lam M, Zhu JW, Maqbool T, Adam G, Tadrous M, Rochon P, et al. Inclusion of older adults in randomized clinical trials for systemic medications for atopic dermatitis: a systematic review. JAMA Dermatol 2020; 156: 1240-1245.
https://doi.org/10.1001/jamadermatol.2020.2940
Wollenber A, Christen-Zäch S, Taieb A, Paul C, Thyssen JP, de Bruin-Weller M, et al. ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children. J Eur Acad Dermatol Venereol 2020; 34: 2717-2744.
https://doi.org/10.1111/jdv.16892
Institut National de la Statistique et des Etudes économiques. Jeunes de 18 à 29 ans - France, portrait social. Edition 2019 [in French] [cited 2023 Dec 27]. Available from: https://www.insee.fr/fr/statistiques/4238379?sommaire=4238781
Richard MA, Corgibet F, Beylot-Barry M, Barbaud A, Bodemer C, Chaussade V, et al. Sex- and age-adjusted prevalence estimates of five chronic inflammatory skin diseases in France: results of the « OBJECTIFS PEAU » study. J Eur Acad Dermatol Venereol 2018; 32: 1967-1971.
https://doi.org/10.1111/jdv.14959
Theodosiou G, Montgomery S, Metsini A, Dalgard FJ, Svensson Å, Kobyletzki LB. Burden of atopic dermatitis in Swedish adults: a population-based study. Acta Derm Venereol 2019; 99: 964-970.
https://doi.org/10.2340/00015555-3257
Zink A, Arents B, Fink-Wagner A, Seitz I, Mensing U, Wettemann N, et al. Out-of-pocket costs for individuals with atopic eczema: a cross-sectional study in nine European countries. Acta Derm Venerol 2019; 99: 263-267.
https://doi.org/10.2340/00015555-3102
Patruno C, Napolitano M, Argenziano G, Peris K, Ortoncelli M, Girolomoni G, et al. Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real-life study. J Eur Acad Dermatol Venereol 2021; 35: 958-964.
https://doi.org/10.1111/jdv.17094
Weidinger S, Natalija N. Atopic dermatitis. Lancet 2016; 387: 1109-1122.
https://doi.org/10.1016/S0140-6736(15)00149-X
Williamson S, Merritt J, De Benedetto A. Atopic dermatitis in the elderly: a review of clinical and pathophysiology hallmarks. Br J Dermatol 2020; 182: 47-54.
https://doi.org/10.1111/bjd.18652
Chan AR, Sandhu VK, Drucker AM, Fleming P, Lynde CW. Adult-onset atopic dermatitis: presentations and progress. J Cutan Med Surg 2020; 24: 267-272.
https://doi.org/10.1177/1203475420911896
Silverberg JI, Vakharia PP, Chopra R, Sacotte R, Patel N, Immaneni S, et al. Phenotypical differences of child- and adult-onset atopic dermatitis. J Allergy Clin Immunol Pract 2018; 6: 1306-1312.
https://doi.org/10.1016/j.jaip.2017.10.005
Woo YR, Han Y, Lee JH, Lee YB, Kim JE, Kim M, et al. Real-world prevalence and burden of genital eczema in atopic dermatitis: a multicenter questionnaire-based study. J Dermatol 2021; 48: 625-632.
https://doi.org/10.1111/1346-8138.15817
Silverberg JI, Margolis D, Boguniewicz M, Fonacier L, Grayson M, Ong P, et al. Distribution of atopic dermatitis lesions in United States adults. J Eur Acad Dermatol Venereol 2019; 33: 1341-1348.
https://doi.org/10.1111/jdv.15574
Zuberbier T, Orlow SJ, Paller AS, Taïeb A, Allen G, Hernanz-Hermosa JM, et al. Patient perspectives on the management of atopic dermatitis. J Allergy Clin Immunol 2006;118: 226-232.
https://doi.org/10.1016/j.jaci.2006.02.031
Silverberg JI, Garg NK, Paller AS, Fishbein AB, Zee PC. Sleep disturbances in adults with eczema are associated with impaired overall health: a US population-based study. J Invest Dermatol 2015; 135: 56-66.
https://doi.org/10.1038/jid.2014.325
Halioua B, Corgibet F, Taieb C, Thenie C, Veniard C, Noel M, et al. Therapeutic inertia in the management of patients with inadequately controlled atopic dermatitis. J Eur Acad Dermatol Venereol 2022; 36: e817-e818.
https://doi.org/10.1111/jdv.18303
Food and Drug Administration. FDA requires warnings about increased risk of serious heart-related events, cancer, blood clots, and death for JAK inhibitors that treat certain chronic inflammatory conditions. 09.01.2021 FDA Drug Safety Communication [cited 2023 Dec 27]. Available from: https://www.fda.gov/drugs/drug-safety-and-availability/fda-requires-warnings-about-increased-risk-serious-heart-related-events-cancer-blood-clots-and-death
Fishbein AB, Silverberg JI, Wilson EJ, Ong PY. Update on atopic dermatitis: diagnosis, severity assessment, and treatment selection. J Allergy Clin Immunol Pract 2020; 8: 91-101.
https://doi.org/10.1016/j.jaip.2019.06.044
Williams HC, Burney PG, Hay RJ, Archer CB, Shipley MJ, Hunter JJ, et al. The U.K. working party's diagnostic criteria for atopic dermatitis: derivation of a minimum set of discriminators for atopic dermatitis. Br J Dermatol 1994;131: 383-396.
https://doi.org/10.1111/j.1365-2133.1994.tb08530.x
Kim JP, Chao LX, Simpson EL, Silverberg JI. Persistence of atopic dermatitis (AD): a systematic review and meta-analysis J Am Acad Dermatol 2016; 75: 681-687.
Published
How to Cite
License
Copyright (c) 2024 Clément Pollyn-Millot, François Maccari, Jean Luc Perrot, Ziad Reguiai, Claire Boulard, Pierre André Becherel, Claire Poreaux, Laure Mery-Bossard, Domitille Beaulieu, Diane Pourchot, Anne-Claire Fougerousse, Edouard Begon, Anne-Laure Liegeon, Charlotte Fite; Inès Zaraa; Dominique Lons-Danic, Beatrice Walls, Caroline Jacobzone, Charlotte Lepelley, Daphné Denis, Guillaume Chaby
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
